Results 311 to 320 of about 151,741 (352)

Calcium channel blockers as tocolytics

Seminars in Perinatology, 2001
This article reviews the clinical and basic science investigations regarding the safety and efficacy of calcium channel blockers as tocolytic agents. The authors reviewed the English language literature on the pharmacology and clinical applications of calcium antagonists in obstetrics.
K E, Economy, A Z, Abuhamad
openaire   +2 more sources

Calcium channel blockers in hypertension

International Journal of Cardiology, 1989
Review of the role of calcium channel blockers, verapamil, nifedipine and diltiazem in ...
openaire   +2 more sources

Calcium channel blocker overdose

The American Journal of Emergency Medicine, 1995
A case of diltiazem overdose with significant hemodynamic compromise is presented. Multiple therapeutic modalities were attempted with limited results. Control was finally achieved with a combination of norepinephrine, dobutamine, and cardiac pacing.
L, Proano, W K, Chiang, R Y, Wang
openaire   +2 more sources

Calcium Channel Blockers and Atherosclerosis

Journal of Cardiovascular Pharmacology, 1990
There is evidence that calcium antagonists (calcium channel blockers) may suppress atheroma formation in animals fed high-fat diets. Studies on the antiatherosclerotic effects of calcium blockers have suggested a variety of possible mechanisms: (a) lowering of arterial pressure, (b) decrease in atherogenic plasma lipoproteins, (c) suppression of ...
openaire   +2 more sources

Calcium Channel Blockers in Systemic Hypertension

Medical Clinics of North America, 1987
Alterations in transmembrane flux of calcium ions may be playing a role in the pathophysiology of systemic hypertension. Calcium channel blockers have been shown to be effective antihypertensive drugs with excellent safety profiles. They are efficacious in the long term treatment of systemic hypertension in all population subgroups, and have special ...
W H, Frishman, J A, Stroh, S, Greenberg, T, Suarez, A, Karp, H, Peled   +5 more
openaire   +3 more sources

Calcium channel blockers and the kidney

Clinical Cornerstone, 2004
Although end-stage renal disease (ESRD) currently affects only a small percentage (
openaire   +2 more sources

Calcium Channel Blockers

Journal of Pharmacy Practice, 1990
Calcium is an integral component in numerous physiological processes and functions. As such, drugs that interfere with the movement of calcium into or out of cells, or the activity of intracellular calcium are useful in treating a variety of disease states.
Jean M. Nappi, Jacqueline S. Marinac, Patricia Bartlomé   +2 more
openaire   +1 more source

Calcium Channel Blockers, Beta Blockers and the Maintenance of Calcium Homeostasis

1986
A properly functioning myocardium is well equipped to maintain ionic homeostasis. Each myocyte is surrounded by a selectively permeable membrane into which are inserted the various ionic pumps, the ion-selective, voltage-activated and receptor operated channels, and the ion transporters, including the Na+-Ca2+ exchanger (Figure 1).
W G, Nayler, W J, Sturrock
openaire   +2 more sources

Calcium channel blockers and stroke.

Aging clinical and experimental research, 2005
The most frequent indication for Calcium Channel Blockers (CCBs) is their use as antihypertensive agents for primary or secondary stroke prevention. Hypertension contributes to virtually all mechanisms of stroke, of atherothrombotic, lacunar, cardioembolic and intraparenchymal hemorrhage types.
INZITARI, DOMENICO, POGGESI, ANNA
openaire   +2 more sources

Calcium Channel Blockers

Clinical Obstetrics and Gynecology, 1995
D, Ray, D, Dyson
openaire   +2 more sources